共 22 条
[2]
[Anonymous], 2018, FDA drug safety communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body
[3]
requires new class warnings
[4]
[Anonymous], 1977, BIRTH DEFECTS DRUGS
[10]
KANO Y, 1983, CANCER RES, V43, P1493